Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A3482 Icotinib HydrochlorideSummary: EGFR inhibitor,potent and specific
-
A3487 Imatinib hydrochlorideSummary: V-Abl/c-Kit/PDGFR inhibitor
-
A3500 IRAK inhibitor 12 CitationTarget: IRAKSummary: IRAK-4 inhibitor
-
A3501 IRAK inhibitor 2Summary: IRAK inhibitor
-
A3502 IRAK inhibitor 3Target: IRAKSummary: IRAK inhibitor
-
A3503 IRAK inhibitor 4Target: IRAKSummary: IRAK inhibitor
-
A3504 IRAK inhibitor 6Target: IRAKSummary: IRAK-4 inhibitor
-
A3505 IRAK-1-4 Inhibitor I3 CitationTarget: IRAKSummary: IRAK-1/4 inhibitor
-
A3513 IxabepiloneSummary: Epothilone B analog;microtubule-stabilizing agent
-
A3527 Ki20227Target: c-Fms tyrosine kinaseSummary: C-Fms tyrosine kinase inhibitor